McCoy The cohort included 351,913 adults aged 21 years and older with type 2 diabetes and moderate risk for CVD who filled an initial prescription for a GLP-1 drug , SGLT2 inhibitor, DPP-IV inhibitor or sulfonylurea from 2014 to 2021 (mean age, 65.3 years
This mechanism is well-documented: a peer-reviewed review in Drugs evaluating Sermorelins use in the diagnosis and treatment of growth hormone deficiency confirms it works by stimulating endogenous pituitary GH release through the GHRH receptor
A minimum of 2 sessions per week of bodyweight or weighted resistance exercise is recommended
Findings were replicated in a separate study population of patients with T2D during a non-overlapping period
In fact, obesity treatment guidelines emphasize that GLP-1 medication should be combined with a high-protein diet, increased physical activity, and behavioral interventions (self-tracking, therapy, group support, dietary education, etc.)